1. Home
  2. CGTX vs IPWR Comparison

CGTX vs IPWR Comparison

Compare CGTX & IPWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGTX
  • IPWR
  • Stock Information
  • Founded
  • CGTX 2007
  • IPWR 2007
  • Country
  • CGTX United States
  • IPWR United States
  • Employees
  • CGTX N/A
  • IPWR N/A
  • Industry
  • CGTX Biotechnology: Pharmaceutical Preparations
  • IPWR Industrial Machinery/Components
  • Sector
  • CGTX Health Care
  • IPWR Industrials
  • Exchange
  • CGTX Nasdaq
  • IPWR Nasdaq
  • Market Cap
  • CGTX 53.4M
  • IPWR 52.8M
  • IPO Year
  • CGTX 2021
  • IPWR 2013
  • Fundamental
  • Price
  • CGTX $2.41
  • IPWR $5.33
  • Analyst Decision
  • CGTX Strong Buy
  • IPWR Hold
  • Analyst Count
  • CGTX 3
  • IPWR 1
  • Target Price
  • CGTX $2.83
  • IPWR N/A
  • AVG Volume (30 Days)
  • CGTX 12.4M
  • IPWR 101.8K
  • Earning Date
  • CGTX 08-07-2025
  • IPWR 08-14-2025
  • Dividend Yield
  • CGTX N/A
  • IPWR N/A
  • EPS Growth
  • CGTX N/A
  • IPWR N/A
  • EPS
  • CGTX N/A
  • IPWR N/A
  • Revenue
  • CGTX N/A
  • IPWR $19,240.00
  • Revenue This Year
  • CGTX N/A
  • IPWR N/A
  • Revenue Next Year
  • CGTX N/A
  • IPWR $9,900.00
  • P/E Ratio
  • CGTX N/A
  • IPWR N/A
  • Revenue Growth
  • CGTX N/A
  • IPWR N/A
  • 52 Week Low
  • CGTX $0.22
  • IPWR $3.77
  • 52 Week High
  • CGTX $3.83
  • IPWR $8.85
  • Technical
  • Relative Strength Index (RSI)
  • CGTX 61.15
  • IPWR 57.54
  • Support Level
  • CGTX $2.26
  • IPWR $5.01
  • Resistance Level
  • CGTX $2.67
  • IPWR $5.35
  • Average True Range (ATR)
  • CGTX 0.40
  • IPWR 0.27
  • MACD
  • CGTX -0.03
  • IPWR 0.04
  • Stochastic Oscillator
  • CGTX 42.08
  • IPWR 61.01

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

About IPWR Ideal Power Inc.

Ideal Power Inc is pioneering the development of its broadly patented bidirectional power switches, creating efficient and ecofriendly energy control solutions for electric vehicles, electric vehicle charging, renewable energy, energy storage, UPS / data center, solid-state circuit breaker and other industrial and military applications. The company is focused on its patented Bidirectional, Bipolar Junction Transistor (B-TRAN) semiconductor technology. B-TRAN is a double-sided bidirectional AC switchable to deliver substantial performance improvements over conventional power semiconductors. The primary raw material used in the fabrication of B-TRAN devices is silicon wafers.

Share on Social Networks: